Special Issue: Call for papers for Adavance Healthcare and Evolutionary Medicine

Aims and scope of the special issue:

IJLSCI announces the launch of a special Issue “Call for papers on Adavance Healthcare, drug and therapeutics and Evolutionary Medicine”. We invite original articles, reviews and commentaries addressing this important subject. Our previous special issue on "Covid-19 in India: An Inter-disciplinary perspectives on the global pandemic"  has been a great success and we hope the new issue will help in advancing the cause of scientific enquiry and knowledge most needed to deal with the current pandemic.

Submission instructions:

Manuscripts are invited with the goal of publishing the IJLSCI Call for papers on Adavance Healthcare, drug and therapeutics and Evolutionary Medicine.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. IJLSCI is an international peer-reviewed open access quarterly journal.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 250 USD. Submitted papers should be well formatted and use good English. 

All submissions will undergo normal peer-review. Please ensure to select the appropriate article type “SPI- AHEM” when submitting your paper.

https://ijlsci.in/ls/index.php/home/about/submissions

Important dates

First submission expected: 15 Nov 2024

Submission deadline: 15 Dec 2024

For questions regarding this special issue, please contact:

Dr. Arvind Chavhan  editor@ijlsci.in